HEALIUS LIMITED — Director's Dealing 2026

Apr 22, 2026

Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Katherine Ostin
Date of last notice	13 March 2026

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and indirect
Nature of indirect interest (including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.	The Director has an interest in securities held by Nitso Pty Limited ATF The Ostin-Shortus Family Trust. The Director is a director of Nitso Pty Limited and a beneficiary of The Ostin-Shortus Family Trust.

The Director has an interest in shares held by Citicorp Nominees Pty Limited on behalf of CPU Share Plans Pty Ltd for Katherine Ostin as the beneficial owner. |
| Date of change | 23 April 2026 |
| No. of securities held prior to change | 21,779 Ordinary shares (Direct)
49,890 Ordinary shares (Indirect)
45,955 Share Rights (Indirect) |
| Class | Fully paid ordinary shares (Restricted) |
| Number acquired | 22,978 |
| Number disposed | Nil |

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

---

Appendix 3Y

Change of Director's Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	The Share Rights were issued in November 2025 at $0.8704 per Share Right.
No. of securities held after change	21,779 Ordinary shares (Direct) 49,890 Ordinary shares (Indirect) 22,977 Share Rights (Direct) 22,978 Ordinary shares (Restricted)
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Vesting of Share Rights issued under the NED Share Plan in lieu of Director fees into fully paid ordinary shares.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Nil
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 – ${}^{+}$ Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

Authorised by: Kylie Brown, Company Secretary

Date: 23 April 2026

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011